Clincosm LogoSign in Get a demo

Lymphoma, Extranodal NK-T-Cell

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

Recruiting
  • T-cell Non-Hodgkin Lymphoma
  • Lymphoma, Extranodal NK-T-Cell
  • Busan, Korea, Republic of
  • +1 more
Aug 17, 2022

Lymphoma, Extranodal NK-T-Cell Trial in Shanghai (Pembrolizumab, Involved Field Radiation Therapy)

Recruiting
  • Lymphoma, Extranodal NK-T-Cell
  • Shanghai, China
    Shanghai Rui-Jin Hospital
Mar 29, 2022

Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • Registry of patients (exposure is Cutaneous Lymphoma)
  • Barcelona, Spain
  • +13 more
Mar 15, 2022

Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell Trial run by the NCI (Alemtuzumab (Campath), EPOCH)

Completed
Has Results
  • Lymphoma, T-Cell
  • Lymphoma, Extranodal NK-T-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 3, 2022

Lymphoma, Extranodal NK-T-Cell Trial in Seoul (avelumab)

Active, not recruiting
  • Lymphoma, Extranodal NK-T-Cell
  • Seoul, Korea, Republic of
    81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Sep 22, 2021

Lymphoma, Extranodal NK-T-Cell, EBV Trial in Worldwide (baltaleucel-T)

Terminated
  • Lymphoma, Extranodal NK-T-Cell
  • EBV
  • baltaleucel-T
  • Boston, Massachusetts
  • +10 more
Mar 12, 2019

Lymphoma, Extranodal NK-T-Cell Trial in GuangZhou (Gemcitabine, Oxaliplatin, Pegaspargase)

Terminated
  • Lymphoma, Extranodal NK-T-Cell
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 8, 2018

Lymphoma, Extranodal NK-T-Cell Trial in GuangZhou (gemcitabine, oxaliplatin, pegaspargase)

Terminated
  • Lymphoma, Extranodal NK-T-Cell
  • GuangZhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 8, 2018

Lymphoma, Extranodal NK-T-Cell Trial in Chengdu (GLIDE)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 6, 2017

Lymphoma, Extranodal NK-T-Cell Trial in Beijing (18F-FDG PET/CT)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • 18F-FDG PET/CT
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Feb 9, 2017

Lymphoma, Extranodal NK-T-Cell Trial in Beijing (18F-FDG PET/ CT)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • 18F-FDG PET/ CT
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Feb 9, 2017

Lymphoma, Extranodal NK-T-Cell, EBV Trial (Chidamide BIW, Chidamide QD)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • EBV
  • Chidamide BIW
  • Chidamide QD
  • (no location specified)
Aug 22, 2016

Lymphoma, Extranodal NK-T-Cell Trial in Guangzhou (GELOX, IFRT)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center; State Key Laboratory of On
Apr 18, 2016

Lymphoma, Extranodal NK-T-Cell Trial in Xi'an (MESA chemo, MESA)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • Xi'an, Shaanxi, China
    Department of Hemaology, Xi jing Hospital,The Fourth Military Me
Dec 21, 2013